drugset / Trial / NCT02041338
Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
There are no standard neodjuvant regimens adapted according to the different subtypes of breast cancer. This is a phase 2, randomized study to evaluate several regimens in different subtypes of breast cancer.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Comparator | Epirubicin | Small molecule | 75 mg/m2 | — |
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | — |